Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析

◆英語タイトル:Aurinia Pharmaceuticals Inc (AUP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15071
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly Isotechnika Pharma Inc, is a clinical stage biopharmaceutical company which develops and commercializes therapies for the treatment of diseases with high unmet medical need. Its pipeline products include Voclosporin, is an investigational drug for the treatment of lupus nephritis and focal segmental glomerulosclerosis; and voclosporin ophthalmic solution for dry eye syndrome. It serves the needs of patients and physicians by providing access to therapeutic options and disease awareness. Aurinia Pharmaceuticals works in partnership with patient advocacy groups, healthcare providers and researchers to deliver treatments to people suffering from debilitating diseases. It has operations in Canada and the US. Aurinia Pharmaceuticals is headquartered in Victoria, British Columbia, Canada.

Aurinia Pharmaceuticals Inc Key Recent Developments

Nov 08,2018: Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development
Aug 28,2018: Aurinia Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018
Aug 09,2018: Aurinia reports second quarter financial results and operational highlights
May 10,2018: Aurinia Announces 2018 First Quarter Financial Results
Mar 15,2018: Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights

This comprehensive SWOT profile of Aurinia Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aurinia Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Aurinia Pharmaceuticals Inc – Key Information
Aurinia Pharmaceuticals Inc – Overview
Aurinia Pharmaceuticals Inc – Key Employees
Aurinia Pharmaceuticals Inc – Key Employee Biographies
Aurinia Pharmaceuticals Inc – Key Operational Heads
Aurinia Pharmaceuticals Inc – Major Products and Services
Aurinia Pharmaceuticals Inc – History
Aurinia Pharmaceuticals Inc – Company Statement
Aurinia Pharmaceuticals Inc – Locations And Subsidiaries
Aurinia Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Aurinia Pharmaceuticals Inc – Business Description
Aurinia Pharmaceuticals Inc – Corporate Strategy
Aurinia Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Aurinia Pharmaceuticals Inc – Strengths
Aurinia Pharmaceuticals Inc – Weaknesses
Aurinia Pharmaceuticals Inc – Opportunities
Aurinia Pharmaceuticals Inc – Threats
Aurinia Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Aurinia Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Aurinia Pharmaceuticals Inc, Key Information
Aurinia Pharmaceuticals Inc, Key Ratios
Aurinia Pharmaceuticals Inc, Share Data
Aurinia Pharmaceuticals Inc, Major Products and Services
Aurinia Pharmaceuticals Inc, History
Aurinia Pharmaceuticals Inc, Key Employees
Aurinia Pharmaceuticals Inc, Key Employee Biographies
Aurinia Pharmaceuticals Inc, Key Operational Heads
Aurinia Pharmaceuticals Inc, Other Locations
Aurinia Pharmaceuticals Inc, Subsidiaries
Aurinia Pharmaceuticals Inc, Key Manufacturing facilities
Aurinia Pharmaceuticals Inc, Key Competitors
Aurinia Pharmaceuticals Inc, SWOT Analysis
Aurinia Pharmaceuticals Inc, Ratios based on current share price
Aurinia Pharmaceuticals Inc, Annual Ratios
Aurinia Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Aurinia Pharmaceuticals Inc, Performance Chart
Aurinia Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Victek Co., Ltd.:企業の戦略・SWOT・財務情報
    Victek Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Victek Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ZoomMed Inc (ZMD)-医療機器分野:企業M&A・提携分析
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • Klox Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Klox Technologies Inc (Klox Technologies) is a biomedical technology company that researches, develops and commercializes fluorescence biomodulation (FB) technology products for the treatment of skin and soft tissue disorders. The company develops FB systems to address conditions in the ther …
  • Harley-Davidson Inc (HOG):企業の財務・戦略的SWOT分析
    Harley-Davidson Inc (HOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mediq NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediq NV (Mediq) is a provider of medical devices, pharmaceuticals and related care services. It offers these services directly to people’s homes (direct), through professional healthcare customers such as hospitals and care institutions (institutional), through wholesalers or through Mediq …
  • ICICI Lombard General Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Lombard General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Lombard General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Calpine Corp:企業の戦略的SWOT分析
    Calpine Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kuwait Petroleum International Ltd:企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Broncus Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc is a medical device company that develops navigation, diagnostic and therapeutic technologies. The company’s products comprise lungpoint virtual bronchoscopic navigation system, lungpoint satellite planning system, and flexneed …
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • VA Tech Wabag Ltd (WABAG):企業の財務・戦略的SWOT分析
    Summary VA Tech Wabag Ltd (VA Tech) is engaged in the planning, design, installation and operation of water and wastewater plants. The company’s services include water treatment, desalination, waste water treatment, water reclamation, and sludge treatment. Its projects comprise Sundarijal Water Trea …
  • Kellogg Co:企業のM&A・事業提携・投資動向
    Kellogg Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kellogg Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • SteadyMed Therapeutics Inc:製品パイプライン分析
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …
  • Hexcel Corp (HXL):企業の財務・戦略的SWOT分析
    Hexcel Corp (HXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ImpediMed Ltd (IPD):製品パイプライン分析
    Summary ImpediMed Ltd (ImpediMed) is a manufacturer of bioimpedance devices with a focus on medical applications in the fluid status domain. It designs, manufactures and sells bioimpedance spectroscopy (BIS) devices for assessing lymphoedema and body composition. The major products of the company in …
  • TAQA North Ltd:企業の戦略的SWOT分析
    TAQA North Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Alibaba Pictures Group Limited:企業のM&A・事業提携・投資動向
    Alibaba Pictures Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alibaba Pictures Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Solasia Pharma KK (4597)-製薬・医療分野:企業M&A・提携分析
    Summary Solasia Pharma KK (Solasia Pharma) formerly JapanBridge Inc is a healthcare service provider that provides patient access to Western oncology therapies. The company develops and commercializes oncology therapies and cancer supportive care products. Its products include transdermal system whi …
  • Verastem Inc (VSTM):企業の財務・戦略的SWOT分析
    Summary Verastem Inc (Verastem) is a biopharmaceutical company which focus on the discovery, development and commercialization of novel small molecule drugs to treat cancer. The company’s marketed product COPIKTRA, an oral inhibitor of phosphoinositide 3-kinase (PI3K) is used to hematologic malignan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆